National Centre for Pharmacoeconomics

National Centre for

NCPE Ireland

Indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who have failed to respond to or who have a contraindication to, or are intolerant to systemic non-biologic therapies including cyclosporine, methotrexate or psoralen and ultraviolet A light (PUVA).

Rapid Review

Commenced Completed Outcome
24/02/2015 03/04/2015 Full Pharmacoeconomic Evaluation Recommended.

Pharmacoeconomic Evaluation

Commenced Completed Outcome
28/07/2015  27/01/2016 Reimbursement Not Recommended at the Submitted Price.


The HSE has approved reimbursement following confidential price negotiations October 2017.